INDOCO REMEDIES LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 Aug 2024
Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation
Source:
BSE India